AAAAAA

   
Results: 1-3 |
Results: 3
Use of trifluoroperazine isolates a [H-3]ifenprodil binding site in rat brain membranes with the pharmacology of the VoltageIndependent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits
Authors: Coughenour, LL Barr, BM
Citation: Ll. Coughenour et Bm. Barr, Use of trifluoroperazine isolates a [H-3]ifenprodil binding site in rat brain membranes with the pharmacology of the VoltageIndependent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits, J PHARM EXP, 296(1), 2001, pp. 150-159
Milameline (CI-979/RU35926): A muscarinic receptor agonist with cognition-activating properties: Biochemical and in vivo characterization
Authors: Schwarz, RD Callahan, MJ Coughenour, LL Dickerson, MR Kinsora, JJ Lipinski, WJ Raby, CA Spencer, CJ Tecle, H
Citation: Rd. Schwarz et al., Milameline (CI-979/RU35926): A muscarinic receptor agonist with cognition-activating properties: Biochemical and in vivo characterization, J PHARM EXP, 291(2), 1999, pp. 812-822
4-hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl) piperidine: A novel, potent, and selective NR1/2B NMDA receptor antagonist
Authors: Zhou, ZL Cai, SX Whittemore, ER Konkoy, CS Espitia, SA Tran, MT Rock, DM Coughenour, LL Hawkinson, JE Boxer, PA Bigge, CF Wise, LD Weber, E Woodward, RM Keana, JFW
Citation: Zl. Zhou et al., 4-hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl) piperidine: A novel, potent, and selective NR1/2B NMDA receptor antagonist, J MED CHEM, 42(15), 1999, pp. 2993-3000
Risultati: 1-3 |